COMPASS PATHWAYS PLC Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- COMPASS PATHWAYS PLC stock issued during period, value, new issues for the quarter ending 2026-03-31 was $131.29M, a 139.50% increase year-over-year.
- COMPASS PATHWAYS PLC stock issued during period, value, new issues for the quarter ending 2025-03-31 was $54.82M, a 109.07% increase year-over-year.
- COMPASS PATHWAYS PLC stock issued during period, value, new issues for the quarter ending 2024-03-31 was $26.22M, a 2106.99% increase year-over-year.
- COMPASS PATHWAYS PLC stock issued during period, value, new issues for the quarter ending 2023-09-30 was $116.61M.
- COMPASS PATHWAYS PLC stock issued during period, value, new issues for fiscal 2025 was $54.82M.
- COMPASS PATHWAYS PLC stock issued during period, value, new issues for fiscal 2022 was $440.00K, a 99.72% decline from fiscal 2021.
- COMPASS PATHWAYS PLC stock issued during period, value, new issues for fiscal 2021 was $154.79M, a 16.59% increase from fiscal 2020.
- COMPASS PATHWAYS PLC stock issued during period, value, new issues for fiscal 2020 was $132.76M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $131.29M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $54.82M 10-K · filed 2026-03-24 | |
| 2025-03-31 | $54.82M 10-Q · filed 2026-08-05 | |
| 2024-03-31 | $26.22M 10-Q · filed 2024-10-31 | |
| 2023-09-30 | $116.61M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $26.93M 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $1.19M 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $440.00K 10-K · filed 2024-02-29 | |
| 2021-12-31 | $154.79M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $23.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $154.79M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $132.76M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |